Incidental Mutation 'P0005:Nek6'
ID 7632
Institutional Source Beutler Lab
Gene Symbol Nek6
Ensembl Gene ENSMUSG00000026749
Gene Name NIMA (never in mitosis gene a)-related expressed kinase 6
Synonyms 1300007C09Rik
MMRRC Submission 038262-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.118) question?
Stock # P0005 (G1)
Quality Score
Status Validated
Chromosome 2
Chromosomal Location 38401655-38484618 bp(+) (GRCm39)
Type of Mutation critical splice donor site (2 bp from exon)
DNA Base Change (assembly) T to C at 38459749 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000108523 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000054234] [ENSMUST00000112895] [ENSMUST00000112902]
AlphaFold Q9ES70
Predicted Effect probably null
Transcript: ENSMUST00000054234
SMART Domains Protein: ENSMUSP00000049723
Gene: ENSMUSG00000026749

DomainStartEndE-ValueType
S_TKc 45 310 3.01e-91 SMART
Predicted Effect probably null
Transcript: ENSMUST00000112895
SMART Domains Protein: ENSMUSP00000108516
Gene: ENSMUSG00000026749

DomainStartEndE-ValueType
S_TKc 45 310 3.01e-91 SMART
Predicted Effect probably null
Transcript: ENSMUST00000112902
SMART Domains Protein: ENSMUSP00000108523
Gene: ENSMUSG00000026749

DomainStartEndE-ValueType
S_TKc 34 299 3.01e-91 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000203964
Meta Mutation Damage Score 0.9500 question?
Coding Region Coverage
  • 1x: 85.5%
  • 3x: 80.5%
  • 10x: 66.1%
  • 20x: 49.6%
Validation Efficiency 95% (104/109)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a kinase required for progression through the metaphase portion of mitosis. Inhibition of the encoded protein can lead to apoptosis. This protein also can enhance tumorigenesis by suppressing tumor cell senescence. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
PHENOTYPE: No significant homozygous or heterozygous mutant phenotype was detected in a high throughput screen of a targeted mutation, however these homozygotes exhibit an increased response of the heart to induced stress, with aggravated cardiac hypertrophy. [provided by MGI curators]
Allele List at MGI

All alleles(128) : Targeted(3) Gene trapped(125)

Other mutations in this stock
Total: 20 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Atp13a1 T C 8: 70,256,397 (GRCm39) V845A possibly damaging Het
Casp6 T C 3: 129,705,792 (GRCm39) V153A probably benign Het
Col6a1 A G 10: 76,553,163 (GRCm39) probably benign Het
Dars2 A G 1: 160,881,509 (GRCm39) probably null Het
Hmgcll1 T A 9: 75,982,041 (GRCm39) M162K possibly damaging Het
Hydin A T 8: 111,220,921 (GRCm39) probably null Het
Ift74 A G 4: 94,550,813 (GRCm39) probably benign Het
Itpr1 A T 6: 108,358,218 (GRCm39) I595F probably damaging Het
Mgat4f T A 1: 134,315,646 (GRCm39) M15K probably benign Het
Mmp17 T C 5: 129,673,695 (GRCm39) V258A probably benign Het
Nomo1 A T 7: 45,686,981 (GRCm39) probably null Het
Nudt3 A G 17: 27,815,689 (GRCm39) probably benign Het
Pramel32 A G 4: 88,546,187 (GRCm39) L385P probably damaging Het
Prkg2 A C 5: 99,117,806 (GRCm39) F512V probably damaging Het
Ptp4a3 T A 15: 73,627,160 (GRCm39) D72E possibly damaging Het
Rpgrip1l A T 8: 92,025,853 (GRCm39) probably benign Het
Rrp9 G A 9: 106,358,376 (GRCm39) R101H probably benign Het
Slc7a6os T C 8: 106,931,154 (GRCm39) I161V probably benign Het
Tex15 T C 8: 34,060,896 (GRCm39) F109L probably benign Het
Tns2 A G 15: 102,022,491 (GRCm39) Q1188R probably damaging Het
Other mutations in Nek6
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL03112:Nek6 APN 2 38,450,914 (GRCm39) missense probably damaging 1.00
R0014:Nek6 UTSW 2 38,448,856 (GRCm39) splice site probably benign
R0674:Nek6 UTSW 2 38,448,916 (GRCm39) missense possibly damaging 0.79
R0709:Nek6 UTSW 2 38,447,858 (GRCm39) missense probably damaging 0.99
R0835:Nek6 UTSW 2 38,459,643 (GRCm39) missense possibly damaging 0.76
R1548:Nek6 UTSW 2 38,458,907 (GRCm39) missense probably damaging 0.99
R1773:Nek6 UTSW 2 38,472,431 (GRCm39) missense probably benign 0.25
R1901:Nek6 UTSW 2 38,472,458 (GRCm39) missense probably damaging 1.00
R4080:Nek6 UTSW 2 38,440,649 (GRCm39) missense probably damaging 0.99
R4563:Nek6 UTSW 2 38,475,305 (GRCm39) missense probably damaging 1.00
R6207:Nek6 UTSW 2 38,447,846 (GRCm39) missense possibly damaging 0.82
R6865:Nek6 UTSW 2 38,459,678 (GRCm39) missense probably benign
R7339:Nek6 UTSW 2 38,450,977 (GRCm39) missense probably damaging 1.00
R8536:Nek6 UTSW 2 38,404,797 (GRCm39) splice site probably null
Protein Function and Prediction

The Aspergillus nidulans 'never in mitosis A' (NIMA) gene encodes a serine/threonine kinase that controls initiation of mitosis. NIMA-related kinases (NEKs) are a group of protein kinases that are homologous to NIMA. Evidence suggests that NEKs perform functions similar to those of NIMA (OMIM *604884). Nek6 is proposed to regulate p70 ribosomal S6 kinase activity, indicating that Nek6 is involved in growth signal transduction pathways (1).  siRNA of Nek6 results in cell arrest in M phase and triggers apoptosis (2).  Furthermore, examination of cell cycle progress after treatment with a kinase-inactive mutant of Nek6 showed mitotic arrest at metaphase before the cells progressed to apoptosis, indicating that Nek6 is required for the metaphase-anaphase transition (2).  Later studies showed that Nek6-induced cell cycle arrest upon DNA damage is a result of DNA damage-induced phosphorylation (3).  Nek6 is upregulated in various human cancers and Nek6 expression is decreased in both replicative senescence of normal fibroblasts as well as p53-induced premature senescence, indicating that Nek6 may have a role in tumorigenesis (4).

Expression/Localization

During early embryogenesis, Nek6 is expressed in primary giant trophoblast cells (5).  In later embryogenesis, expression of Nek6 is restricted to the nervous system (5). In the adult brain, Nek6 is expressed primarily in the piriform cortex, the archicortex. Lower levels were observed in the amygdala, olfactory bulb, and the hindbrain (5).  In addition, Nek6 was found to be expressed in the intestine, ovary, and the granulosa cells of large growing and antral follicles (5).

Genotyping

P0005:Nek6 (NEK6 ICSI) genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the single nucleotide transition.
 

PCR Primers

NEK6 ICSI(F): 5’- GTTGCTTTCACCTGTGTGAGACCC-3’

NEK6 ICSI(R): 5’- AAGCCAGGCAGATGCAGTCCATTC-3’

Sequencing Primer

NEK6 ICSI_seq(F): 5’- TGTTACAGATGAATAAATGAGCC-3’

NEK6 ICSI_seq(R): 5’- GCAGTCCATTCTATATGACAGGGTC-3’
 

PCR program

1) 94°C             2:00

2) 94°C             0:30

3) 55°C             0:30

4) 72°C             1:00

5) repeat steps (2-4) 40X

6) 72°C             10:00

7) 4°C               ∞

The following sequence of 667 nucleotides (from GenBank genomic region NC_000068 encoding Nek6) is amplified:

57659                                                                gt

57661 tgctttcacc tgtgtgagac cctgccctag tcactgcagt gcaaagctta ctgactgtca

57721 gacagtgtct cccgtgcggt gacgctcgtc tggcacaggg gaggcagctg tacaaaagga

57781 gacagtagta tagaagtctc tgctccccac tcacagccaa cctgtgacat gggggagggg

57841 gatagtcatg ttacagatga agtaaatgag cctcctccca tcccttctaa gcctgctctc

57901 cccacaccaa ccctgtgtcc ttgccctgca gacatcaagc ccgccaacgt gttcatcaca

57961 gctacgggca ttgtgaagct tggtgacctc ggcctgggcc gcttcttcag ctcggagacc

58021 actgcggccc actcactagg taagaggcct atgtcccacc tacccgcagc ccctgtaggc

58081 ctgggtgacc cagccggaag ggcatccatt ctcctggaac tatttgtagt gtgtgggaag

58141 atcttttttg agtcttaaga gttcaccctt gctttgggat agatccaaag tagaggaaac

58201 tgaggcccag aggggccact gcagggggga agggggatct ccccatatcc ccaagtcatc

58261 tctctagtac ttcctggaag gccaacagac cctgtcatat agaatggact gcatctgcct

58321 ggctt

Primer binding sites are underlined and the sequencing primer is highlighted; the mutated nucleotide is shown in red text.

References
Posted On 2012-10-05
Science Writer Anne Murray